Sarah Burton-Jones I FSHD – Diagnosis or no diagnosis? The benefits and limitations of genomic testing aligned to 2024 best practice guidelines I Tues 1st April I Online Attendance Only

Date: Tuesday 1st April 2025

Time: 12.30 – 13.30

Title:  FSHD – Diagnosis or no diagnosis? The benefits and limitations of genomic testing aligned to 2024 best practice guidelines

Speaker:  Sarah Burton-Jones, Clinical Laboratory Scientist, Bristol, South West Genetic Lab

Abstract: TBC

Location: Online only.

Cost: Free

Registration: If you would like to attend this lunchtime seminar session, please contact: mrcc@mft.nhs.uk